Skip to Content

UK Edition. Click here for US version.


Active substance(s): METHOTREXATE

PDF options:  View Fullscreen   Download PDF

PDF Transcript

Methotrexate 100 mg/ml Injection
Read all of this leaflet carefully before you start using this
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• If any of the side effects gets serious, or if you notice any side
effects not listed in this leaflet, please tell your doctor.
In this leaflet:
1. What Methotrexate Injection is and what it is used for
2. Before you are given Methotrexate Injection
3. How you are given Methotrexate Injection
4. Possible side effects
5. How to store Methotrexate Injection
6. Further information

Methotrexate Injection is an anti-metabolite medicine (medicine which
affects how the body’s cells grow) and immunosuppressant (medicine which
reduces the activity of the immune system).
Methotrexate is used in large doses (on its own or in combination with other
medicines) to treat certain types of cancer such as breast cancer. In smaller
doses it can be used to treat severe psoriasis (a skin disease with thickened
patches of inflamed red skin, often covered by silvery scales), when it has
not responded to other treatments.

Methotrexate 100 mg/ml Injection must not be injected intrathecally
(into the spine).

You will not be given Methotrexate Injection if you
• are allergic (hypersensitive) to Methotrexate or any of the
ingredients of Methotrexate Injection
• have significant kidney or liver problems
• have been told you have (or think you have) a blood disorder such as low
levels of white blood cells, red blood cells (anaemia) or platelets
• have any infection
• your immune system is not working as well as it should
Tell your doctor if any of the above applies to you before this medicine is

Take special care with Methotrexate Injection if you
• have a stomach ulcer or ulcerative colitis (inflammation and ulceration of
the gut)
• have an infection
• have mild kidney problems
• have a medical condition which causes a build up of fluid in the lining of
your lungs or in your abdomen (the fluid will need to be drained before
methotrexate treatment is started)
• are to have radiotherapy (risk of tissue and bone damage may be
• are to have any vaccinations
Tell your doctor if any of the above applies to you before this medicine is
Special care will also be taken in children, the elderly and in those who are
in poor physical condition.

Taking/using other medicines
Special care is needed if you are taking/using other medicines as some
could interact with methotrexate, for example:
• non-steroidal anti-inflammatory medicines e.g. ibuprofen (medicines
taken for pain relief)
• aspirin or similar medicines (known as salicylates)
• omeprazole, esomeprazole and pantoprazole (medicines used to reduce
the production of stomach acid)
• diuretics (water tablets)
• medicines taken for diabetes (including insulin and tablets)
• antibiotics such as penicillins, sulphonamides, co-trimoxazole,
trimethoprim, tetracycline, chloramphenicol and para-aminobenzoic acid
• phenytoin (medicine often used to treat epilepsy)
• vitamin supplements containing folic acid
• probenecid (medicine used to treat gout)
• nitrous oxide (used for general anaesthesia and pain relief).
Nitrous oxide increases the effect of Methotrexate and can lead to an
increase in some side effects (such as reduced number of blood cells
and platelets and inflammation of mouth).
• retinoids, such as acitretin (a medicine used to treat psoriasis) or
isotretinoin (used to treat severe acne)
• other drugs that may cause damage to your kidneys
• other drugs that may cause damage to your liver
• live virus vaccines
• mercaptopurine (medicine used in the treatment of blood cell cancer)
• theophylline (medicine used in the treatment of asthma)
Please tell your doctor if you are taking or have recently taken any other
medicines, including medicines obtained without a prescription.

Using Methotrexate Injection and drinking alcohol
Do not drink alcohol whilst being treated with Methotrexate as alcohol
increases the risk of liver damage.

Pregnancy and breast-feeding
Tell your doctor if you are pregnant, trying to become pregnant or
breast-feeding before this medicine is used.
This medicine must not be used during pregnancy.
Mothers should not breast-feed whilst treatment with methotrexate is
Due to the risk of birth defects, conception should be avoided during
methotrexate treatment and for at least 6 months after treatment is stopped.
Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines
Do not drive or use machines if you experience any side effect
(e.g. dizziness, drowsiness or blurred vision) which may lessen your ability
to do so.

Important information about one of the ingredients of Methotrexate
This medicinal product contains 0.42 mmol (9.7 mg) sodium per millilitre
(ml) of solution. To be taken into consideration by patients on a low sodium

This medicine may be given by injection (using a syringe) into a
vein (intravenously), into muscle (intramuscularly) or into an artery
(intraarterially). It may also be given by infusion (drip) into a vein. It may be
diluted before it is given.

Your doctor will work out the correct dose of Methotrexate Injection for you
and how often it must be given.
The dose of medicine given to you will depend on the disease being treated,
your medical condition, your age, your size and how well your kidneys are
Before treatment is started your doctor may carry out blood tests to check
the levels of cells in your blood, and also to check how well your kidneys
and liver are working. You may also have a chest X-ray. Further tests may
also be done during and after treatment.

Methotrexate 100 mg/ml Injection
The following information is intended for medical or healthcare
professionals only
Further to the information included in section 3, practical information on the
preparation/handling of the medicinal product is provided here.

Immediate precipitation or turbidity results when combined with certain
concentrations of droperidol, heparin sodium, metoclopramide hydrochloride,
ranitidine hydrochloride in syringe.

Date: 22 Jun 2017
New Component Nº 2017-0006245/3.2
OLD Component Nº 435501

Packaging Site PGS Melbourne
Barcode Nº N/A

BODY TEXT Size 8 pt

Dimensions 118 x 513 mm
Notes N/A
PAR Number PAR-2017-0006245

Time: 14:14
Market United Kingdom
Proof Nº 01

Component Leaflet
Pharma Code FPO
Drawing Nº 88S119-6



If you are given too much or too little Methotrexate Injection
This medicine will be given to you in a hospital, under the supervision of a
doctor. It is unlikely that you will be given too much or too little, however, tell
your doctor or nurse if you have any concerns.

Methotrexate is a very toxic medicine and patients have died, or become
very ill, whilst being treated with it. During treatment you should watch for
any side effects and report them to the doctor.

If any of the following happen, tell your doctor immediately:
• severe allergic reaction - you may experience a sudden itchy rash
(hives), swelling of the hands, feet, ankles, face, lips, mouth or throat
(which may cause difficulty in swallowing or breathing), and you may feel
you are going to faint
• inflammation of the lung with breathlessness – you may develop a
persistent cough, experience pain or difficulty breathing, or become
breathless. This may be associated with changes in a particular type of
white cell in your blood
• symptoms of an infection e.g. fever, chills, achiness, sore throat
• unexpected bleeding e.g. bleeding gums, blood in the urine or in vomit,
or the appearance of unexpected bruises or broken blood vessels
(broken veins)
• black tarry stools
• a sore mouth, particularly if you have a number of ulcers or blisters inside
of the mouth or on the tongue
• skin rashes or blistering to the surfaces of the eyes, nose, vagina or anus
(back passage)
• diarrhoea
• stroke/weakness on one side of the body
• weakness in the legs that spreads to the upper limbs and the face, which
may result in paralysis
• abdominal pain, fatty stools
• vomiting
• chest pain (which may be due to heart or lung problems)
These are serious side effects. You may need urgent medical attention.

If any of the following happen, tell your doctor as soon as possible:

low blood pressure (you may feel faint)
blurred vision or eye infection (conjunctivitis)
difficulty/inability to talk
muscle weakness
you may feel the need to drink more than usual (diabetes)
abnormally easily broken bones (osteoporosis)
pain or redness of the blood vessels (vasculitis)
itching or the appearance of lightened patches on the skin, bruises, boils
increased sensitivity to sunlight
yellowing of the skin and whites of the eyes (jaundice)
pain in the stomach, loins or abdomen
you may need to pass urine more often than usual, which may be painful
• headaches
• drowsiness
• generally feeling tired or unwell
• reduced appetite, feeling or being sick
• irregular periods in women (periods may stop completely)
• hair loss
• effects on learning and memory
• ringing of the ears
• joint and muscle pain
• blood clot which causes pain, swelling or redness (cerebral, deep vein,
retinal vein or arterial vein)
• mood alterations
• inflammation of the lungs, which causes breathlessness, cough and
raised temperature, pneumonia
• shingles (Herpes Zoster)
Methotrexate may lead to problems with your blood, liver and kidneys. Your
doctor will take blood samples to check for these problems and may ask
you to have an operation to have a small sample of your liver removed.
If any of the side effects gets serious, or if you notice any side effects
not listed in this leaflet, please tell your doctor.

Effects on fertility
Treatment with methotrexate may reduce fertility in men and women.
Fertility is thought to go back to normal after methotrexate treatment is
stopped. Tell your doctor if you have concerns.

Keep out of the reach and sight of children

This medicine must not be used after the expiry date which is stated on the
vial label and carton after ‘EXP’. Where only a month and year is stated, the
expiry date refers to the last day of that month.

The vials should be kept in the outer carton, in order to protect from light,
and stored at or below 25°C. The vials should not be frozen.
Unused portions of opened vials must not be stored for later use.
Prepared infusions should be used immediately, however, if this is not
possible they can, in certain circumstances, be stored for up to 30 days in a
refrigerator provided they have been prepared in a way to exclude microbial

What Methotrexate Injection contains
The active substance is methotrexate. Each millilitre (ml) of solution
contains 100 milligrams (mg) of methotrexate.
The other ingredients are sodium hydroxide and Water for Injections.

What Methotrexate Injection looks like and contents of the pack
Methotrexate Injection is a clear, yellow/orange solution for injection which
comes in glass containers called vials.
It may be supplied in packs containing:
1 x 1 g/10 ml vial
1 x 5 g/50 ml vial
Not all packs may be marketed.

Marketing authorisation holder and manufacturer responsible for
batch release in Europe
Hospira UK Limited,
Honey Lane

Hospira Australia Pty Ltd
1-5, 7-23 and 25-39 Lexia Place
This leaflet was last revised in 05/2017
Ref MEgx 1_0

Instructions for use and handling
Single use only. Discard any unused contents.
After dilution, chemical and physical in-use stability has been demonstrated in
dextrose 5% and sodium chloride 0.9% infusion solutions for 30 days at 4°C in
PVC containers when protected from light.
From a microbiological point of view the product should be used immediately.
If not used immediately, in-use storage times and conditions prior to use are
the responsibility of the user and would normally not be longer than 24 hours
at 2-8°C, unless dilution has taken place in controlled and validated aseptic


Date: 22 Jun 2017
New Component Nº 2017-0006245/3.2
OLD Component Nº 435501

Packaging Site PGS Melbourne
Barcode Nº N/A

BODY TEXT Size 8 pt

Dimensions 118 x 513 mm
Notes N/A
PAR Number PAR-2017-0006245

Time: 14:14
Market United Kingdom
Proof Nº 01

Component Leaflet
Pharma Code FPO
Drawing Nº 88S119-6



+ Expand Transcript

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.